Traditional Medicines and Natural Products as Preventive and Therapeutic Agents Against COVID-19

Nabeelah received her M.S. degree in Forensic Science at Staffordshire University (U.K.) in 2016 and her B.S. degree in Chemistry at University of Mauritius (Mauritius) in 2014. Since 2017, she has been pursuing her Ph.D. at the Department of Health Sciences at the University of Mauritius under the supervision of Prof. (Dr.) Fawzi Mahomoodally. Her current research focuses on the phytochemical analysis and pharmacological properties of mangrove plants and their associated fungal endophytes. She is an Associate Member of the Royal Society of Chemistry. Nabeelah is efficient at multitasking, can effectively lead a team and works well either independently or in group. In her short period as PhD student (since 2017), Nabeelah has authored and co-authored 30 publications in high impact factor journals and prestigious books with several other articles and book chapters under preparation/review. Thomas Efferth is chair of the Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany. He is biologist by training (Technical University of Darmstadt, Germany). His doctoral thesis was completed at the German Cancer Research Center (DKFZ), Heidelberg, Germany (1990). Dr. Efferth was awarded the Ludolf-Krehl-Prize of the Southwest German Association for Medicine (1991), the Willmar-Schwabe-Award of the German Society for Medicinal Plant Research (2006), the citizen medal of the City of Heidelberg, Germany (2008), the CESAR Award for Translational Oncology (2011), and the SCENTEDdrop Award on medicinal and flagrant herbs (2015). He headed a research group for Pharmaceutical Biology at DKFZ (2005-2009) and was associate professor (apl) at the University of Heidelberg (2007-2009). In 2009, he took over the Chair of Pharmaceutical Biology (full professorship) at the Johannes Gutenberg University, Mainz. Furthermore, he is honorary professor at the Northeast Forestry University, Harbin, and at the Zhejiang Chinese Medical University, Hangzhou, China. Moreover, he is visiting professor at the Zhejiang University of Science and Technology, Hangzhou, China. He is editor-in-chief, co-editor, associate editor and editorial board member of 30 scientific journals and scientific advisory board member of the German Pharmaceutical Society and several other institutions. Seven of his former lab members promoted to associate or assistant professors. The focus of Dr. Efferth's research is on tumor pharmacology, pharmacogenomics, and the development of novel options for treatment and diagnosis of cancer. A major topic is research on chemical entities from natural sources.

PART I: Traditional herbal medicines 1. Traditional medicines and natural products for COVID-19: Potential and limitations 2. Recent advances of Traditional Chinese medicine against COVID-19 pandemic 3. The efficacy of Ayurvedic medicine in the prevention and treatment of COVID-19 4. Traditional Persian medicine as a holistic therapeutic approach in managing COVID-19 5. The potential application of Kampo medicine against SARS-CoV-2 6. Functional food components for the management and prevention of COVID-19 and its associated 7. The potential of ketogenic dietary therapy in COVID-19 pandemic PART II: Natural products and Natural product-based new medicinal products 8. Flavonoids as potential inhibitors targeting SARS-CoV-2 9. Saponins as potential inhibitors targeting SARS-CoV-2 10. Coumarins as potential inhibitors targeting SARS-CoV-2 11. Alkaloids as potential inhibitors targeting SARS-CoV-2 12. Terpenes and terpenoids as potential inhibitors targeting SARS-CoV-2 13. Polysaccharides as potential inhibitors targeting SARS-CoV-2 14. Evaluating microbial natural products as potential SARS-CoV-2 inhibitors 15. Towards natural polymers and nanoparticles as nano-therapies to combat COVID-19 16. Natural products from mushrooms as versatile therapeutic and preventive inhibitors to COVID-19